Vor Biopharma Inc (NASDAQ: VOR) on Monday, soared 4.43% from the previous trading day, before settling in for the closing price of $0.83. Within the past 52 weeks, VOR’s price has moved between $0.63 and $3.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.14%. With a float of $59.84 million, this company’s outstanding shares have now reached $68.66 million.
The extent of productivity of a business whose workforce counts for 168 workers is very important to gauge. In terms of profitability, gross margin is 77.63%, operating margin of -965.14%, and the pretax margin is -919.87%.
Vor Biopharma Inc (VOR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vor Biopharma Inc is 12.86%, while institutional ownership is 58.87%. The most recent insider transaction that took place on Jun 03 ’24, was worth 20,357. In this transaction CHIEF MEDICAL OFFICER of this company sold 14,645 shares at a rate of $1.39, taking the stock ownership to the 96,063 shares.
Vor Biopharma Inc (VOR) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.39 earnings per share (EPS) for the period topping the consensus outlook (set at -0.5) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.14% per share during the next fiscal year.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Vor Biopharma Inc (VOR) is currently performing well based on its current performance indicators. A quick ratio of 4.69 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.65, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.19 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
The latest stats from [Vor Biopharma Inc, VOR] show that its last 5-days average volume of 0.37 million was inferior to 0.5 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 61.05%. Additionally, its Average True Range was 0.07.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 42.68%, which indicates a significant decrease from 45.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.96% in the past 14 days, which was lower than the 76.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7657, while its 200-day Moving Average is $1.2701. Now, the first resistance to watch is $0.9013. This is followed by the second major resistance level at $0.9335. The third major resistance level sits at $0.9682. If the price goes on to break the first support level at $0.8344, it is likely to go to the next support level at $0.7997. The third support level lies at $0.7675 if the price breaches the second support level.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
Market capitalization of the company is 62.74 million based on 68,674K outstanding shares. Right now, sales total 0 K and income totals -117,863 K. The company made 0 K in profit during its latest quarter, and -27,559 K in sales during its previous quarter.
